Government
PRODUCTS
-
Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.
-
Leveraging extensive expertise and state-of-the-art facilities, Altasciences conducts comprehensive toxicology evaluations to ensure the safety and regulatory compliance of your novel drug candidates.
-
Reduce manual validation efforts, cut costs by up to 30%, get new products out the door faster, and enable seamless regulatory inspections.
-
As your personal partner and pharma consulting expert, we sincerely understand the specific process and regulatory challenges of pharmaceutical, biotech, and medical device manufacturers in detail.
-
Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.
They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.
Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.
WHITE PAPERS AND CASE STUDIES
-
City Of Westminster, Colorado, And The Value Of Trustworthy Data
This case study explores how the City of Westminster in Colorado has implemented a new mobile app, Trimble Unity Mobile for Cityworks, to streamline workflows and reduce manual data entry for water utility crews.
-
Development And Regulation Of Veterinary Monoclonals
Although veterinary mAbs have achieved commercial success, ongoing discussions and clinical developments surrounding them are expected to outline a clear regulatory pathway in the near future.
-
Future-Proofing Life Sciences Manufacturing: 2025 CDMO Trends
Review contract manufacturing's evolution, driven by technological advancements and regulatory changes, and how CMOs and CDMOs are navigating opportunities and challenges.
-
Guide To Navigating The Complex And Expanding Regulatory Landscape
In today’s complex landscape, organizations face growing compliance demands from diverse sources. Learn how a strong compliance system and culture of accountability drive sustainable growth and protect long-term success.
-
Supplier Quality Is Only As Strong As Your Weakest Link
Your supply chain is only as strong as its weakest link. 52% of organizations attribute recalls to supplier-related issues, and proactive supplier quality management is essential to protect your brand.
-
Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer
Discover how digital biomanufacturing is revolutionizing drug production by exploring strategies for integrating digital technologies to enhance efficiency and innovation in bioprocessing workflows.
-
Design Testing Strategies To Develop A Drug-Device Combination Product
Leveraging the expertise and experience of a trusted partner can reduce risk and accelerate the time to market for drug-device combination products by creating an optimal Validation Master Plan.
-
Does Asset Health Monitoring Have A Role In The Water Sector?
See why collaboration with trusted vendors is crucial for deploying reliable, adaptable, and sustainable asset health solutions in the evolving water sector.
-
Best Practices For Internal Quality Audits In Life Sciences
Discover why internal quality audits are vital in the life sciences sector to ensure regulatory compliance, mitigate risks, and maintain high standards of product quality and patient safety amidst evolving challenges.
-
Streamlining Early-Phase Oncology Study Start-Up In Today's Clinical Environment
Explore the significance of targeted therapies and adaptive trial designs that prioritize patient-specific characteristics.
-
Addressing PFAS Contamination In Cape Fear's Source Water: Calgon Carbon's Solution
The Cape Fear Public Utility Authority (CFPUA) provides drinking water to more than 200,000 residents in the Wilmington, North Carolina area. In 2017, the community learned that per- and polyfluoroalkyl substances, or PFAS as they are more commonly referred, were contaminating CFPUA’s drinking water source. This led CFPUA to partner with Calgon Carbon to install Filtrasorb® granular activated carbon (GAC) to remove PFAS from the water at their Sweeney Water Treatment Plant. With this GAC addition, PFAS concentrations were reduced to levels at or near non-detection.
-
What Clinical Trial Decision Makers Are Prioritizing In 2025
In 2025, clinical trial operations are undergoing a transformative shift driven by the need for speed, cost-efficiency, and patient-centered approaches.
NEWS
-
Philippines Launches National Plastic Action Partnership To Tackle Plastic Waste And Advance Circular Economy3/9/2025
The Philippines took a significant step forward in addressing its plastic waste crisis with the launch of the National Plastic Action Partnership (NPAP), a multi-stakeholder platform designed to foster collaboration across sectors and accelerate the country’s transition to a circular economy.
-
Energy NL Writes Provincial Party Leaders And Asks Questions On Key Energy Issues9/16/2025
Since the Provincial General Election of 2021, the Newfoundland and Labrador energy industry has undergone a significant evolution, and substantial opportunities for success are ahead.
-
Hughes And Celona To Deliver Fully Managed Private Wireless Networks10/7/2025
Hughes Network Systems, LLC (Hughes), an EchoStar company, today announced a strategic relationship with Celona, a pioneer in private 5G networks, to launch a fully managed private wireless network solution.
-
From Research To Real-World Solutions: Building Impact Through Strategic Partnerships9/16/2025
For nearly a decade, AIM Photonics has demonstrated how collaboration drives progress in integrated photonics.
-
Latvian Scientists Create A Tool For More Efficient Public Procurement Evaluation1/10/2026
Much of public procurement evaluation consists of manual work by experts and specialists. This is time-consuming, since it involves comparing extensive documentation, evaluating compliance with regulatory requirements—like whether there are competition-restricting criteria—and other factors.